PD-L1 (CD274) Rabbit Polyclonal Antibody
|FC, IF, IHC, WB
|WB: 0.5 - 1 ug/mL, ICC: 2.5 ug/mL, IF: 20 ug/mL
|Human, Mouse, Rat
|PD-L1 antibody was raised against a 17 amino acid synthetic peptide from near the center of human PD-L1. The immunogen is located within amino acids 60 - 110 of PD-L1.
|PBS containing 0.02% sodium azide.
|Affinity chromatography purified via peptide column
|Store at -20°C as received.
|Stable for 12 months from date of receipt.
|Cell-mediated immune responses are initiated by T lymphocytes that are themselves stimulated by cognate peptides bound to MHC molecules on antigen-presenting cells (APC). T-cell activation is generally self-limited as activated T cells express receptors such as PD-1 (also known as PDCD-1) that mediate inhibitory signals from the APC. PD-1 can bind two different but related ligands, PDL-1 and PDL-2. PDL-1 is a B7-related protein that inhibits cell-mediated immune responses by reducing the secretion of IL-2 and IL-10 from memory T cells. This suggests that PDL-1 may be useful in reducing allogenic CD4+ memory T-cell responses to endothelial cells, thereby reducing the likelihood of host immune responses to allografts. At least two isoforms of PDL-1 are known to exist; this antibody is specific to the larger isoform. PDL-1 antibody has no cross-reactivity to PDL-2.
|B7-H; B7H1; PD-L1; PDCD1L1; PDCD1LG1; PDL1
|Druggable Genome, Transmembrane
|Cell adhesion molecules (CAMs)